| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |